3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
24
Pancreatic Cyst
5
Esophageal Neoplasms
4
Pancreatic adenoma
2
Lymphadenopathy
2
Gastrointestinal Neoplasms
2
Cysts
2
Arachnodactyly
2
Adenoma, Islet Cell
2
Subepithelial Gastrointestinal Tumors
1
Stomach Neoplasms
1
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic carcinoma, familial
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Other Specified Disorders of Esophagus, Stomach or Duodenum
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Lymphatic Metastasis
1
Hereditary pancreatitis
1
Gastrointestinal Stromal Tumor of Stomach
1
Esophagus
1
Dysplastic Nevus Syndrome
1
Duodenal Neoplasms
1
Disease
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colorectal Neoplasms
1
Cholangitis, Sclerosing
1
Cholangiocarcinoma
1
Interventions
Endoscopic Ultrasound-Guided Fine Needle Aspiration
2
isatuximab
1
Needles
1
Biopsy, Fine-Needle
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphadenopathy
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Gastrointestinal
×
Clear all
NCT01563133
2017-08-29
CONTACT
Mauna Kea Technologies
Phase NA
Unknown
330 enrolled
NCT01770405
2017-08-29
US-nCLE
Mauna Kea Technologies
Completed
40 enrolled